Biological Markers of Sexual Activity: Tools for Improving Measurement in HIV/Sexually Transmitted Infection Prevention Research

Abstract Research on interventions to prevent HIV and other sexually transmitted infections (STIs) is heavily influenced by participant reporting of sexual behavior, despite uncertainty about its validity. Exclusive reliance on participant self-report often is based, overtly or by implication, on 4 assumptions: (1) no feasible alternatives exist; (2) misreporting can be minimized to levels that can be disregarded; (3) misreporting tends to underreport sensitive behaviors; and (4) misreporting tends to be nondifferential with respect to the groups being compared. The objective of this review are to evaluate these assumptions, including a review of studies using semen biomarkers to evaluate the validity of self-reported data, and to make recommendations for applying biological markers of semen exposure detectable in women to further strengthen research on HIV/STI prevention. Increasing evidence shows that semen biomarkers provide an important means of assessing and augmenting the validity of studies on HIV/STI prevention. Additional biomarkers are needed to assess male exposure to vaginal sex and both male and female exposure to anal sex. Methods and study designs that incorporate biomarkers into studies collecting self-reported behavioral data should be considered where possible.

[1]  C. Black,et al.  Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards. , 2013, Contraception.

[2]  C. Black,et al.  Optimal methods for collecting and storing vaginal specimens for prostate-specific antigen testing in research studies. , 2013, Contraception.

[3]  M. Hobbs,et al.  Randomized Controlled Trial on the Effectiveness of Counseling Messages for Avoiding Unprotected Sexual Intercourse During Sexually Transmitted Infection and Reproductive Tract Infection Treatment Among Female Sexually Transmitted Infection Clinic Patients , 2013, Sexually transmitted diseases.

[4]  A. van der Straten,et al.  Feasibility of a Breath Test for Monitoring Adherence to Vaginal Administration of Antiretroviral Microbicide Gels , 2013, Journal of clinical pharmacology.

[5]  J. Sobel,et al.  Discordance between spermatozoa detection and self-reported semen exposure. , 2011, Sexually transmitted diseases.

[6]  S. Dube,et al.  Estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States. , 2011, American journal of epidemiology.

[7]  P. Hewett,et al.  Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa: An Interview Mode Experiment Using a Placebo Gel , 2011, AIDS and Behavior.

[8]  V. Nguyen,et al.  Biological Validation of Self-Reported Condom Use Among Sex Workers in Guinea , 2010, AIDS and Behavior.

[9]  V. Lipovsek,et al.  Can follow-up study questions about correct and consistent condom use reduce respondent over-reporting among groups at high risk? An analysis of datasets from six countries , 2010, Reproductive health.

[10]  L. Sherr,et al.  How to improve the validity of sexual behaviour reporting: systematic review of questionnaire delivery modes in developing countries , 2010, Tropical medicine & international health : TM & IH.

[11]  A. van der Straten,et al.  American Journal of Epidemiology Practice of Epidemiology Biomarker Validation of Reports of Recent Sexual Activity: Results of a Randomized Controlled Study in Zimbabwe , 2022 .

[12]  D. Grimes,et al.  Social desirability bias in family planning studies: a neglected problem. , 2009, Contraception.

[13]  M. Hobbs,et al.  Good Performance of Rapid Prostate-Specific Antigen Test for Detection of Semen Exposure in Women: Implications for Qualitative Research , 2009, Sexually transmitted diseases.

[14]  A. Turner,et al.  Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews. , 2009, Journal of clinical epidemiology.

[15]  G. Ramjee,et al.  The Use of the Diaphragm Instead of Condoms in a Phase III Diaphragm Trial , 2009, AIDS and Behavior.

[16]  J. Hardin,et al.  The validity of teens' and young adults' self-reported condom use. , 2009, Archives of pediatrics & adolescent medicine.

[17]  David R. Holtgrave,et al.  Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. , 2008, The Cochrane database of systematic reviews.

[18]  A. Kulczycki,et al.  Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. , 2007, American journal of epidemiology.

[19]  S. Luchters,et al.  Validity of self-reported 'safe sex' among female sex workers in Mombasa, Kenya—PSA analysis , 2007, International journal of STD & AIDS.

[20]  M. Hobbs,et al.  Randomised controlled trial on whether advance knowledge of prostate-specific antigen testing improves participant reporting of unprotected sex , 2006, Sexually Transmitted Infections.

[21]  M. Hobbs,et al.  Prostate-Specific Antigen to Ascertain Reliability of Self-Reported Coital Exposure to Semen , 2006, Sexually transmitted diseases.

[22]  S. Noar,et al.  Condom Use Measurement in 56 Studies of Sexual Risk Behavior: Review and Recommendations , 2006, Archives of sexual behavior.

[23]  J. Yuenger,et al.  Polymerase Chain Reaction Detection of Y-Chromosome Sequences in Vaginal Fluid of Women Accessing a Sexually Transmitted Disease Clinic , 2006, Sexually transmitted diseases.

[24]  Ulrike Peters,et al.  Is It Time to Abandon the Food Frequency Questionnaire? , 2005, Cancer Epidemiology Biomarkers & Prevention.

[25]  David H. Martin,et al.  Women Find It Easy and Prefer to Collect Their Own Vaginal Swabs to Diagnose Chlamydia trachomatis or Neisseria gonorrhoeae Infections , 2005, Sexually transmitted diseases.

[26]  M. Zaviačič,et al.  The use of prostate-specific antigen as a criterion for condom effectiveness. , 2005, American journal of epidemiology.

[27]  M. Lawson,et al.  MACALUSO ET AL. REPLY , 2005 .

[28]  M. Macaluso,et al.  Effectiveness of female and male condoms in preventing exposure to semen during vaginal intercourse: a randomized trial. , 2005, Contraception.

[29]  Claude Cheta,et al.  Respondent perspectives on self-report measures of condom use. , 2003, AIDS education and prevention : official publication of the International Society for AIDS Education.

[30]  David R. Holtgrave,et al.  NIMH/APPC workgroup on behavioral and biological outcomes in HIV/STD prevention studies: a position statement. , 2000, Sexually transmitted diseases.

[31]  G. Hortin,et al.  Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure. , 1999, Contraception.

[32]  G. Hortin,et al.  Objective Markers of Condom Failure , 1998, Sexually transmitted diseases.

[33]  G. Sensabaugh,et al.  Postcoital detection of a male-specific semen protein. Application to the investigation of rape. , 1985, The New England journal of medicine.

[34]  R. Brotman,et al.  Effect of menses on clearance of Y-chromosome in vaginal fluid: implications for a biomarker of recent sexual activity. , 2010, Sexually transmitted diseases.